⌘K

Login Start Free

Home/Filings/4/0001019687-03-001917

4//SEC Filing

TAYLOR CLIVE R 4

Accession 0001019687-03-001917

CIK 0000704562other

View on SEC.gov Company Profile

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 6:22 PM ET

Size

9.4 KB

Accession

0001019687-03-001917

Insider Transaction Report

Form 4

Period: 2003-09-17

PEREGRINE PHARMACEUTICALS INCPPHM

Director

Transactions

Exercise/Conversion
Common Stock
2003-09-15$0.34/sh+7,100$2,414→ 26,100 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-09-15$1.80/sh−7,100$12,780→ 1,774,900 total
Exercise: $0.34From: 2001-12-22Exp: 2009-12-22→ Common Stock (7,100 underlying)
Sale
Common Stock
2003-09-16$1.80/sh−16,100$28,980→ 19,000 total
Sale
Common Stock
2003-09-15$1.80/sh−7,100$12,780→ 19,000 total
Exercise/Conversion
Common Stock
2003-09-16$0.34/sh+16,100$5,474→ 35,100 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-09-16$1.80/sh−16,100$28,980→ 1,758,800 total
Exercise: $0.34From: 2001-12-22Exp: 2009-12-22→ Common Stock (16,100 underlying)

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

PEREGRINE PHARMACEUTICALS INC

CIK 0000704562

Entity typeother

Related Parties

1

filerCIK 0001244095

Filing Metadata

Form type: 4
Filed: Sep 16, 8:00 PM ET
Accepted: Sep 17, 6:22 PM ET
Size: 9.4 KB

View on SEC.gov